Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717418 · ClinicalTrials.gov registry record
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 781
- Enrollment target
NCT00717418: Completed study, sponsored by Allergan.
NCT00717418 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 781 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00717418 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 781 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.
Primary Outcome
The OSDI consists of 12 questions to assess visual function, ocular symptoms and environmental triggers related to dry eye. Each of the 12 questions is assessed using a 5-point scale (0=none of the time; 4 = all of the time) which is converted to a total score between 0-100. OSDI total scores of 0-12=normal (best), 13-22= mild ocular surface disease, 23-32 =moderate ocular surface disease, and 33-100=severe ocular surface disease (worst).
Interventions
- DRUG cyclosporine ophthalmic emulsion 0.05%, artificial tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 781 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-08 |
What the finished NCT00717418 record still lists
NCT00717418 is an observational study that tracks outcomes without assigning an intervention. The registered 781 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which cyclosporine ophthalmic emulsion 0.05%, artificial tears is the first listed.
NCT00717418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00717418 about?
NCT00717418 is a clinical study titled "Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease". This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final ...
What is the current status of trial NCT00717418?
This trial is currently completed. The enrollment target is 781 participants. The study started on 2004-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00717418?
The interventions under investigation include: cyclosporine ophthalmic emulsion 0.05%, artificial tears (DRUG).
Who is sponsoring clinical trial NCT00717418?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia